Investigating delays in treatment for heart attack patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to assess how delays before and during hospital treatment affect outcomes for patients experiencing a myocardial infarction (MI). It will track the time from symptom onset to first medical contact and subsequent hospital care, analyzing how these delays influence mortality rates, complications, and recovery times. The study will be conducted at Al-Kadhimiya Teaching Hospital in Baghdad, focusing on patients who receive reperfusion therapy within 12 hours of symptom onset. By understanding these delays, the study hopes to identify factors that can be targeted to improve patient outcomes.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients who provide informed consent (or a legal representative provides consent if the patient is unable to do so).
* Patients who undergo reperfusion therapy, such as thrombolysis or percutaneous coronary intervention (PCI).
* Patients admitted to Al-Kadhimiya Teaching Hospital within 12 hours of symptom onset.

Exclusion Criteria:

* Patients with non-acute myocardial infarction (e.g., stable angina, prior MI).
* Patients with severe comorbidities (e.g., advanced cancer, end-stage renal disease) that may complicate outcome assessments or interfere with treatment protocols.
* Patients who are transferred to another facility before reperfusion therapy is initiated.
* Pregnant women or breastfeeding women.

Where it's running

• College of Medicine - Al-Nahrain University
  Baghdad, Iraq Recruiting

Study contacts

• Study coordinator: Abdulillah R. Khamees
• Email: allaabed987@ced.nahrainuniv.edu.iq
• Phone: +9647838571013

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Risk of malignant arrhythmias after acute coronary syndrome

  This study tracks how often dangerous heart rhythms occur in adults admitted for ACS and looks for patterns that might predict them.

  Recruiting Catharina Ziekenhuis Eindhoven · Eindhoven, North Brabant · NCT07824050

• Smartphone AI help for prehospital ECG readings

  This study tests whether using a smartphone AI (GPT-4o) to help prehospital providers read 12-lead ECGs improves accuracy in diagnosing acute coronary syndromes and related conditions.

  Recruiting École Supérieure de Soins Ambulanciers - College of Higher Education in Prehospital Care · Murten/Morat, Canton of Fribourg · NCT07810686

• Optimal timing of staged complete revascularization in STEMI with multivessel disease

  This trial tests whether performing staged complete revascularization during the hospital stay or after discharge is best for STEMI patients with multivessel disease.

  Recruiting Chonnam National University Hospital · Bucheon-si and 29 other locations · NCT07741721

• BEAT-SHOCK: Baseline Registry for Acute Cardiogenic Shock at Basel

  This registry collects and shares data on adults with cardiogenic shock admitted to University Hospital Basel to help understand how these patients are treated and how they fare.

  Recruiting University Hospital, Basel, Switzerland · Basel, Canton of Basel-City · NCT07643610

• Low-dose IL-2 after heart attack to study tissue-resident regulatory T cells

  Researchers are testing whether low-dose interleukin-2 given after a myocardial infarction can boost tissue-resident regulatory T cells to support heart repair.

  Recruiting at 2 sites Cambridge University Hospitals NHS Foundation Trust · Cambridge, Cambridgeshire and 1 other locations · NCT07610538

• Abbreviated antithrombotic therapy after PCI in AF and MI

  This trial tests whether DOAC-only therapy works as well as DOAC plus clopidogrel after PCI in people with atrial fibrillation and a recent heart attack.

  Recruiting Chonnam National University Hospital · Gwangju, Gwangju · NCT07583784

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.